Former Mexican president and cannabis-legalization activist, Vicente Fox, has noticed that the governments in Latin America are legalizing the use of cannabis, a plant that was once shunned by many countries. As Latin America embraces cannabis, Fox is keen to see Khiron Life Sciences Corp. (TSXV:KHRN), the Canadian cannabis company on which he is a board member, be a cannabis supplier to the 640 million people that reside in the area, according to an article by Bloomberg. To date, 10 governments in Latin America and the Caribbean have passed legalization. Mexico is poised to join others in the region and legalize, which is keeping Khiron busy as they work on establishing themselves in each area as countries finalize their regulations.

“We have a new world,” said Fox. “It’s surprising for an activity that was in the hands of criminals, illegality and the underworld. The paradigm has totally changed.”


Khiron will be launching sales throughout Latin America this year and is currently selling products in Colombia. Medical cannabis sales in the region are expected to reach $15 million by 2025, according to an estimate by BMO Capital Markets. Additionally, they have recently entered into a joint venture with Colorado-based Dixie Brands Inc. (CSE:DIXI.U) to market a line of medicinal products with cannabis cultivated in four countries in the region. Under the joint venture, Khiron will be supplying the product and obtain the necessary approvals and licenses, and Dixie Brands will provide the formulas and brands.

To read the full article, click here.

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN) for an Investor Presentation.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (“ Avicanna ” or the “ Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that Janet Giesselman has resigned from her role as an independent director of the Company to pursue other opportunities.

Keep reading... Show less

A renowned global bank with wealth management options has elected to block some cannabis trades from clients as part of its de-risking efforts after recent issues.

Also this week, a Canadian cannabis producer announced its intention to buy a retail operator managing nearly 100 stores in the country.

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) ( CSE: HARV OTCQX: HRVSF ), a vertically integrated cannabis company and multi-state operator in the U.S., today announced a settlement agreement has been reached for Agrimed Industries of PA, LLC (“AGRiMED”). The membership interests of AGRiMED are owned by Harvest Health and Recreation Inc.

Keep reading... Show less

Receives processing license for the commercial production and sale of cannabinoids using biosynthesis

Announces plans to launch Spinach™ branded edibles to the Canadian adult-use market

Keep reading... Show less